C
하나제약
293480KOSPI의약품 제조업49.3 / 100
Reference Date: 2026-07-24
Financial Score16.5 / 40
News Sentiment18.8 / 25
Momentum7.0 / 20
Disclosure7.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but Operating Profit is on a declining trend. Slightly down 2.0% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
Hana Pharmaceutical specializes in the production and sale of specialty pharmaceuticals, with a strong presence in analgesics and anesthetics. The company offers a wide range of health insurance-listed drugs and operates manufacturing plants in Hwaseong, Gyeonggi, along with an R&D center in Pangyo.
Number of Employees
706people
Average Salary
53.0M KRW
Score Calculation Basis
Detailed Financial Score
PER
16.79Industry Average 11.233.0Point
Higher than industry avg (caution)
PBR
0.48Industry Average 0.815.5Point
Lower than industry avg (good)
ROE
2.82Industry Average 4.012.5Point
Below industry avg
Debt Ratio
12.95Industry Average 12.432.0Point
Higher than industry avg (caution)
Trend 2023~20253.5 / 10 points
Revenue Growth Rate
1.0 / 3
Avg ▲3.3% (2-year basis)
Operating Profit Growth Rate
0.5 / 3
Avg ▼2.2% (2-year basis)
ROE Trend
2.0 / 4
Avg ROE 6.1% (declining, 3yr)
Detailed News Sentiment
1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 75
- Positive7년 품은 삼진제약 판 하나제약…233억 어디에 쓰나
하나제약이 삼진제약 지분 매각으로 233억 원을 확보해 생산시설 및 R&D 투자를 확대하며 경쟁력 강화를 추진할 것으로 예상된다.
Detailed Momentum
52-week position1.0Point
Near 52w low (6%, downtrend)
Current 8,510Won52-week high 12,29052-week low 8,250
1-month return3.0Point
1m -1.96% (flat)
Volume trend3.0Point
Volume flat
Detailed Disclosure
1 totalPositive 0Neutral 0Negative 1
- Negative불성실공시법인지정2026-07-03